Fortress Biotech, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €49.69M -31.8% -€39.63M -24.1% -79.8% -0.080 pp -€56.17M -45.7% -113.0% +0.29 pp
    €72.81M +11.6% -€52.24M -30.0% -71.7% +0.43 pp -€103.50M -31.9% -142.1% +0.91 pp
    €65.26M +10.1% -€74.59M +33.8% -114.3% -0.20 pp -€151.93M +76.0% -232.8% -0.87 pp
    €59.27M +50.9% -€55.74M +39.1% -94.1% +0.080 pp -€86.32M +30.9% -145.6% +0.22 pp
    €39.29M +24.5% -€40.08M +16.4% -102.0% +0.071 pp -€65.92M -10.6% -167.8% +0.66 pp
    €31.56M +36.3% -€34.43M -52.5% -109.1% +2.0 pp -€73.72M -4.4% -233.6% +0.99 pp
    €23.16M -85.7% -€72.50M +25.8% -313.0% -2.8 pp -€77.10M +11.9% -332.9% -2.9 pp
    €161.61M +1,038.3% -€57.62M +21.4% -35.7% +3.0 pp -€68.91M +126.5% -42.6% +1.7 pp
    €14.20M +1,809.6% -€47.47M +13.8% -334.3% +53 pp -€30.42M +320.5% -214.2% +7.6 pp
    €743.52K +∞% -€41.72M +137.6% -5,611.6% -56 pp -€7.23M -48.6% -973.0% -9.7 pp
    €0.00 +NaN% -€17.56M -45.1% N/A -€14.07M -44.6% N/A
    €0.00 +NaN% -€32.01M +34.6% N/A -€25.38M +28.6% N/A
    €0.00 +NaN% -€23.79M -24.1% N/A -€19.74M +222.3% N/A
    €0.00 +NaN% -€31.33M +264.3% N/A -€6.12M +25.5% N/A
    €0.00 +NaN% -€8.60M +172.3% N/A -€4.88M +141.1% N/A
    €0.00 -€3.16M N/A -€2.02M N/A

    Notifications